Novel Bruton's tyrosine kinase inhibitor remibrutinib: Assessment of drug-drug interaction potential as a perpetrator of cytochrome P450 enzymes and drug transporters and the impact of covalent binding on possible drug interactions-Reference-Cited by-同舟云学术

Novel Bruton's tyrosine kinase inhibitor remibrutinib: Assessment of drug-drug interaction potential as a perpetrator of cytochrome P450 enzymes and drug transporters and the impact of covalent binding on possible drug interactions

Published:2022-05 Issue: Volume:172 Page:106155
ISSN:0928-0987
Container-title:European Journal of Pharmaceutical Sciences
language:en
Short-container-title:European Journal of Pharmaceutical Sciences

Author:

Schiller Hilmar^ORCID,Huth Felix,Schuhler Carole,Drollmann Anton,Kaul Martin,Woessner Ralph,Shah Bharti,Weis Wendy,End Peter^ORCID

Funder

Novartis

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference22 articles.

1. Teratogenic drugs and their drug interactions with hormonal contraceptives;Ahn;Clinical pharmacology and therapeutics,2016

2. Discovery of LOU064 (Remibrutinib), a Potent and Highly Selective Covalent Inhibitor of Bruton's Tyrosine Kinase;Angst;J Med Chem,2020

3. Estimating systemic exposure to levonorgestrel from an oral contraceptive;Basaraba;Contraception,2017

4. The conduct of in vitro and in vivo drug-drug interaction studies: a Pharmaceutical Research and Manufacturers of America (PhRMA) perspective;Bjornsson;Drug Metab Dispos,2003

5. Update on overall prevalence of major birth defects;MMWR. Morbidity and mortality weekly report,2008

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A review of Bruton’s tyrosine kinase inhibitors in multiple sclerosis;Therapeutic Advances in Neurological Disorders;2024-01

2. Update and Application of a Deep Learning Model for the Prediction of Interactions between Drugs Used by Patients with Multiple Sclerosis;Pharmaceutics;2023-12-19

3. Metabolite profiling of remibrutinib in rat and human liver microsomes using liquid chromatography combined with benchtop orbitrap high‐resolution mass spectrometry;Biomedical Chromatography;2023-08-31